Unleashing the Power of Patents: Competitive Analysis in Material Science [Korean webinar] Webinar Unleashing the Power of Patents: Competitive Analysis in Material Science [Korean webinar] CertaraMarch 21, 2025
The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects Publication The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects Find out how high‑fat meals significantly reduce ondansetron exposure, falling outside bioequivalence bounds, analysed using…CertaraMarch 21, 2025
Protect confidential information in investigational drug submissions Blog Protect confidential information in investigational drug submissions March 20, 2025 Health regulatory agencies require pharmaceutical companies to protect study participants’ personal information…CertaraMarch 20, 2025
Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study Publication Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study The IMPAACT 2017/MOCHA study, a phase 1/2 multicenter trial across five countries, assessed the safety,…CertaraMarch 20, 2025
Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan Announcement Certara & A2Healthcare accelerate Model-informed Drug Development (MIDD) adoption in Japan RADNOR, PA – March 18, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraMarch 19, 2025
FDA requirements for providing datasets for nonclinical studies in SEND format Blog FDA requirements for providing datasets for nonclinical studies in SEND format March 19, 2025 The CDISC Standard for the Exchange of Nonclinical Data (SEND) provides the…Peggy ZornMarch 19, 2025
Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRASG12C, in Healthy Chinese Subjects` Publication Effect of Food on the Pharmacokinetic Characteristics of a Single Oral Dose of D-1553, a Selective Inhibitor of KRASG12C, in Healthy Chinese Subjects` Explore how high‑fat meals cause only modest PK changes in D‑1553, supporting administration without regard…CertaraMarch 18, 2025
Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics Capabilities Announcement Certara Enters Strategic Partnership with Biowaived to Increase Biopharmaceutics Capabilities March 17, 2025 Radnor, PA – – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraMarch 17, 2025
Libra product overview Brochure Libra product overview Discover Libra, the innovative tool that transforms DILI prediction in early drug discovery. By optimizing…CertaraMarch 14, 2025
How biosimulation and virtual trials can bust through clinical trial roadblocks Press Coverage How biosimulation and virtual trials can bust through clinical trial roadblocks Discover how using biosimulation for rare disease drug development can help overcome statistical and recruitment…CertaraMarch 14, 2025